FilingSEC EDGAR8-K
Valion Bio Highlights CDMO Capabilities of Subsidiary Velocity Bioworks
· SEC accepted
StageCommercial
Filing content
Valion Bio highlighted the capabilities of its subsidiary, Velocity Bioworks, in providing process development and GMP manufacturing services for early-phase biologics in the U.S.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…